Creative Medical Technology Holdings, Inc

CELZNASDAQ · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

6.49M

on 2026-06-30, from 1.35M on 2024-03-31 10-Q ↗

Newest

S-3 of 2025-11-21. Not read yet. S-3 ↗

9 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-07 is not read yet.

Cash

5.9 quarters

$8.7M on 2026-06-30 ÷ $1.5M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 14 of its filings are not read yet.